CAS 28523-86-6
:Sevoflurane
- 1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane
- 347mmzEβγ
- Ether, fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl
- Fluoromethyl 1,1,1,3,3,3-hexafluoro-2-propyl ether
- Fluoromethyl 1,1,1,3,3,3-hexafluoroisopropyl ether
- Fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
- Mr 6S4
- R-E 347
- Sevocris
- Sevoflo
- Sevofluran
- Sevoflurane
- Sevofrane
- Sevohale
- Sevorane
- Ultane
- Fluoromethyl 1,1,1,3,3,3-hexafluoropropan-2-yl ether
- 1,1,1,3,3,3-Hexafluor-2-(fluormethoxy)propan
- oxyde de fluorométhyle et de 2,2,2-trifluoro-1-(trifluorométhyl)éthyle
- Propane, 1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)-
- See more synonyms
Fluoromethyl 1,1,1,3,3,3-Hexafluoroisopropyl Ether
CAS:Formula:C4H3F7OPurity:>98.0%(GC)Color and Shape:Colorless to Almost colorless clear liquidMolecular weight:200.06Sevoflurane
CAS:Ethers of monohydric alcohols, nesoiFormula:C4H3F7OColor and Shape:Colorless Clear LiquidMolecular weight:200.05Propane, 1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)-
CAS:Formula:C4H3F7OPurity:98%Color and Shape:LiquidMolecular weight:200.0548Sevoflurane
CAS:Formula:(CF3)2CHOCH2FPurity:≥ 99.5%Color and Shape:Clear, colourless liquidMolecular weight:200.06Fluoromethyl 2H-hexafluoroprop-2-yl ether
CAS:Fluoromethyl 2H-hexafluoroprop-2-yl etherFormula:C4H3F7OPurity:≥95%Color and Shape: clear. colourless liquidMolecular weight:200.05484g/molSevoflurane
CAS:Sevoflurane (Fluoromethyl), a noncompetitive inhibitor of 5-HT3 receptor, acts as a low-soluble inhalation anesthetics.Formula:C4H3F7OPurity:98%Color and Shape:Less Oil Colorless OilMolecular weight:200.05Ref: TM-T22425
2mg39.00€5mg54.00€10mg75.00€25mg110.00€50mg158.00€100mg226.00€200mg339.00€1mL*10mM (DMSO)56.00€1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane
CAS:Controlled ProductApplications 1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane is an volatile anesthetic which inhibited activation of inflammatory neutrophil and granulocyte in human blood during simulated extracorporeal circulation.
References Schmid, E., et al.: Int. Immunopharmacol., 14, 202 (2012); Citerio, G., et al.: Euro. J. Anaesthesiol., 29, 371 (2012);Formula:C4H3F7OColor and Shape:NeatMolecular weight:200.051,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane
CAS:Formula:C4H3F7OPurity:98%(GC);RGColor and Shape:Liquid, ClearMolecular weight:200.056Sevoflurane
CAS:Controlled ProductSevoflurane is an experimental drug that belongs to the group of intravenous anaesthetics. It has been shown to be effective in the prevention and treatment of myocardial infarcts. Sevoflurane inhibits polymerase chain reaction by binding to dinucleotide phosphate, which prevents DNA synthesis. It also inhibits oxidative injury in the heart, as well as genotoxic activity. Sevoflurane is a potent chemical inhibitor of the ryanodine receptor, which regulates calcium release from the sarcoplasmic reticulum. This inhibition results in reduced contractility and relaxation of vascular smooth muscle cells, leading to vasodilation and increased blood flow.
Formula:C4H3F7OPurity:Min. 95%Color and Shape:Colorless PowderMolecular weight:200.05 g/mol












